title: HPV vaccination in head and neck HPV-related pathologies.
abstract: Recent data demonstrate that human papilloma virus (HPV) plays a role in pathologies other than ano-genital cancers, specifically head and neck malignancies, and non-cancerous conditions such as recurrent respiratory papillomatosis (RRP). High-risk HPV16 and 18, and low risk HPV6 and 11 play the main role in HPV-related pathologies. As more and more information about the role of HPV infection in non-cervical diseases is amassed, additional questions about whether prophylactic HPV vaccines will effectively prevent these conditions are raised. HPV vaccination programs for the cervical pathology are being implemented worldwide. In the United States, the US Food and Drug Administration (FDA) approved the quadrivalent HPV vaccine for girls in 2006 and for boys in 2011. These vaccination programs were aimed at the genital, HPV-related lesions, and there was not much recognition at that time of how HPV vaccination programs might affect oral HPV infection, which is a risk factor for the development of HPV-related head and neck cancers. Vaccination has proved to be a successful policy, and an extant recommendation is aimed at preventing HPV and associated cervical and other anogenital cancers with the routine use of HPV vaccines for males and females. However, HPV vaccines are presently not recommended for preventing oropharyngeal cancer (OPC), although they have been shown to be highly effective against the HPV strains that are most commonly found in the oropharynx. This review is aimed at presenting the evidence-based knowledge concerning HPV vaccination and highlighting the trials and strategies for vaccine administration in HPV-dependent head and neck pathologies.
authors: Katedra i Klinika Otolaryngologii i Onkologii Laryngologicznej UM w Poznaniu, Kierownik: Prof. dr hab. Witold Szyfter, Poland. Electronic address: gowierzb@yahoo.co.uk.
authors: Małgorzata
authors: M
authors: Wierzbicka
authors: Katedra i Klinika Otolaryngologii i Onkologii Laryngologicznej UM w Poznaniu, Kierownik: Prof. dr hab. Witold Szyfter, Poland.
authors: Agata
authors: A
authors: Józefiak
authors: Katedra i Klinika Otolaryngologii i Onkologii Laryngologicznej UM w Poznaniu, Kierownik: Prof. dr hab. Witold Szyfter, Poland.
authors: Joanna
authors: J
authors: Jackowska
authors: Klinika Otolaryngologii Dziecięcej UM w Poznaniu, Kierownik: dr hab. Jarosław Szydłowski, Poland.
authors: Jarosław
authors: J
authors: Szydłowski
authors: Zakład Wirusologii Molekularnej, Wydział Biologii Uniwersytetu im. Adama Mickiewicza w Poznaniu, Poland.
authors: Anna
authors: A
authors: Goździcka-Józefiak
mesh_terms: D000293:Adolescent; D005260:Female; D006258:Head and Neck Neoplasms / Q000517:prevention & control*; D006291:Health Policy; D006801:Humans; D017589:Immunization Programs / Q000592:standards*; D008297:Male; D030361:Papillomavirus Infections / Q000150:complications* / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D012141:Respiratory Tract Infections / Q000517:prevention & control*; D014481:United States; D014611:Vaccination / Q000592:standards*
chemical_list: D053918:Papillomavirus Vaccines
keywords: HPV; Laryngeal papillomatosis; Oral cavity cancer; RRP; Vaccine; brodawczakowatość krtani; rak jamy ustnej i gardła; szczepionki